Telangana Chief Minister A. Revanth Reddy believes Hyderabad can transition from a global vaccine capital to a global life sciences capital. At the BioAsia 2026 event, he highlighted Hyderabad’s success as a life sciences hub. Reddy expressed optimism that BioAsia could achieve recognition similar to the World Economic Forum in Davos.
The Chief Minister emphasized Telangana’s strengths that would facilitate its evolution into a global life sciences capital. These strengths include a strong vision, clear policy framework, availability of highly qualified human resources, and reputable educational institutions. Hyderabad’s status as a global hub for Global Capability Centres (GCCs) was also noted for its excellence in research and design.
Reddy mentioned key initiatives such as the launch of the Telangana Next-Gen Life Sciences Policy, expansion of Genome Valley, establishment of 1Bio for research and innovation, development of Green Pharma City, and the setup of various global capability centers in Hyderabad. He highlighted that the region has attracted over Rs 73,000 crore in life sciences investments over the past two years.
Hyderabad is positioned as a preferred destination for setting up GCCs, fostering innovation, designing molecules and drugs, managing clinical analytics, developing AI platforms, and promoting digital manufacturing. Reddy suggested that the BioAsia conference could potentially be rebranded as Bio-World due to its global appeal. The presence of key leaders in pharma, bio-sciences, bio-tech, bulk drugs, vaccines, and healthcare in Hyderabad was also emphasized.
Minister D. Sridhar Babu outlined the state’s ambitious targets of $25 billion in life sciences investments and creation of 5 lakh jobs by 2030. The goal is to position Telangana among the top three life sciences clusters globally. The state aims to transition from supply-led manufacturing to solution-driven global leadership by nurturing talent in mRNA, gene editing, and AI-led drug discovery. Hyderabad is envisioned as a hub for next-generation innovation and medical tourism.
BioAsia 2026 witnessed the participation of over 4,000 delegates representing 500 top companies in the global lifesciences ecosystem. The Chief Minister honored Prof Bruce Levine from the University of Pennsylvania with the Genome Valley Excellence Award.
